A Randomized, Controlled Trial of Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in Chronic Pain Patients. — CFSMEATLAS
E1 ReplicatedPreliminaryPEM not requiredRCTPeer-reviewedMachine draft
Standard · 3 min
A Randomized, Controlled Trial of Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in Chronic Pain Patients.
Benor, Daniel, Rossiter-Thornton, John, Toussaint, Loren · Journal of evidence-based complementary & alternative medicine · 2017 · DOI
Quick Summary
This small pilot study tested whether a self-help technique called WHEE (combining eye movements with tapping) could help people with chronic pain, depression, and anxiety. Twenty-four patients with chronic pain conditions (including 17 with ME/CFS or fibromyalgia) were split into two groups: one received WHEE treatment for 6 weeks while the other waited. The WHEE group showed improvements in anxiety and depression compared to those who waited, and when the waiting group later tried WHEE, they also experienced less pain and depression.
Why It Matters
Many ME/CFS patients experience significant comorbid depression, anxiety, and pain that limit quality of life and treatment options. This study suggests WHEE, a low-cost self-administered technique, may offer symptom relief for these overlapping conditions in ME/CFS populations, warranting larger controlled trials. The incidental finding of high childhood/adulthood trauma rates in chronic pain patients also highlights potential psychological dimensions relevant to ME/CFS management.
Observed Findings
WHEE treatment resulted in statistically significant anxiety reduction compared to waitlist control (P < .05)
WHEE treatment resulted in statistically significant depression reduction compared to waitlist control (P < .05)
Waitlist patients who subsequently received WHEE showed significant pain severity reduction (P < .05)
Waitlist patients who subsequently received WHEE showed significant depression reduction (P < .04)
WHEE did not significantly reduce pain interference or anxiety in the waitlist-turned-WHEE group
Inferred Conclusions
WHEE appears to be a promising self-administered method for reducing anxiety and depression in chronic pain patients with ME/CFS or fibromyalgia
WHEE may reduce pain severity in chronic pain populations
The technique warrants further investigation in larger, well-controlled trials
Childhood and/or adulthood psychological trauma may be prevalent in chronic pain patients and could be relevant to symptom management
Remaining Questions
Does WHEE produce sustained benefits beyond 3 months, or do effects diminish over time?
What This Study Does Not Prove
This small pilot study does not establish that WHEE is an effective primary treatment for ME/CFS or that it works better than other therapeutic approaches. The convenience sample and lack of standardized ME/CFS case definitions limit generalizability. The correlation between trauma history and chronic pain observed does not prove trauma causes ME/CFS, nor does it establish that addressing trauma will cure the condition.
Tags
Symptom:Pain
Method Flag:Weak Case DefinitionSmall SampleMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →